Table 1.
Clinical characteristics for patient groups with and without bacteremia.
| With bacteremia (n = 42) | Without bacteremia (n = 38) | p-Valued | |
|---|---|---|---|
| Age (years)a | 72 (16–96) | 60 (20–88) | 0.011 |
| Sex (female)b | 21 (50%) | 22 (58%) | 0.479 |
| Clinical findings at hospitalizationb | |||
| Temperature (°C) | 38.8 (36.9–41.4) | 38.6 (36.6–41.5) | 0.780 |
| Heart rate (/min) | 108 (67–140) | 112 (75–136) | 0.900 |
| Respiratory frequency (/min) | 24 (15–60) | 25 (11–53) | 0.552 |
| Systolic BP (mmHg) | 120 (65–191) | 126 (86–160) | 0.338 |
| Organ failureb,c | |||
| Total SOFA ≥2 | 36 (85%) | 16 (42%) | <0.001 |
| Any failure SOFA ≥2 | 28 (67%) | 10 (26%) | 0.010 |
| Respiratory failure | 17 (40%) | 10 (26%) | 0.181 |
| Hypotension | 9 (21%) | 3 (8%) | 0.090 |
| Bleeding disorder | 5 (12%) | 1 (3%) | 0.107 |
| Renal failure | 7 (17%) | 3 (8%) | 0.236 |
| Liver failure | 2 (5%) | 1 (3%) | 0.616 |
| CNS failure | 3 (7%) | 2 (5%) | 0.729 |
| Infection siteb | 0.003 | ||
| Urinary tract | 20 (48%) | 17 (45%) | |
| Respiratory | 5 (12%) | 13 (34%) | |
| Abdominal | 3 (7%) | 0 | |
| Soft tissue | 4 (10%) | 8 (21%) | |
| CNS | 4 (10%) | 0 | |
| Endocarditis | 6 (14%) | 0 | |
| Bacteriab | 0.044 | ||
| Gram-negative | 25 (60%) | 12 (32%) | |
| Gram-positive | 15 (36%) | 23 (61%) | |
| Mixed Gram-pos./neg. | 2 (5%) | 3 (8%) | |
| Microbe not sensitive to initial treatment | 3 (7%) | 1 (3%) | 0.342 |
| Hospitalization atb | 0.103 | ||
| HDU | 23 (55%) | 16 (42%) | |
| Medical ward | 13 (31%) | 20 (53%) | |
| ICU | 6 (14%) | 2 (5%) | |
| Hospitalization (days)b | 7.5 (2–55) | 7 (2–50) | 0.399 |
| Mortalityb | 1 (2%) | 3 (7%) | 0.259 |
| Routine biochemistrya | |||
| Hgb (g/dL) | 12.5 (8.7–15.4) | 13.0 (9.2–17.5) | 0.429 |
| WBC (109/L) | 13.6 (2.0–27.9) | 14.2 (4.9–46.6) | 0.776 |
| Neutrophils (109/L) | 12.1 (1.6–24.3) | 12.1 (4.1–41.1) | 0.866 |
| CRP (mg/L) | 175 (3–457) | 158 (7–538) | 0.071 |
| Creatinine (μmol/L) | 108 (48–706) | 70 (27–475) | 0.001 |
aMedian (min–max), Mann–Whitney U test.
bN(%), χ2 test.
cDefined as increase in sequential (sepsis-related) organ failure assessment score ≥2, sepsis induced (pre-existing, stable organ failure not included).
dSignificant values are displayed in bold.